Status:
COMPLETED
Study Of Perennial Allergic Rhinitis
Lead Sponsor:
GlaxoSmithKline
Conditions:
Rhinitis, Allergic, Seasonal
Eligibility:
All Genders
16+ years
Phase:
PHASE3
Brief Summary
This study was designed to assess safety of an investigational nasal spray in the treatment of perennial allergic rhinitis. Perennial allergic rhinitis is triggered by house dust, mite and mold etc. T...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Informed consent.
- Outpatient.
- Diagnosis of perennial allergic rhinitis with symptoms.
- Able to comply with study procedures.
- Exclusion criteria:
- Significant concomitant medical condition.
- Use of corticosteroids/allergy medications.
- Laboratory abnormality.
- Positive pregnancy test.
Exclusion
Key Trial Info
Start Date :
June 21 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 12 2005
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT00358475
Start Date
June 21 2005
End Date
October 12 2005
Last Update
August 31 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site